<DOC>
	<DOCNO>NCT00553215</DOCNO>
	<brief_summary>RATIONALE : Studying quality life patient bladder cancer may help determine long-term effect bladder cancer may help improve quality life patient future . PURPOSE : This clinical trial study quality life patient bladder cancer .</brief_summary>
	<brief_title>Quality Life Patients With Bladder Cancer</brief_title>
	<detailed_description>OBJECTIVES : - To study effect recurrence progression health-related quality life ( HRQL ) . - To study effect repeat cystoscopy HRQL . - To study patient ' assessment hypothetical prognostic model affect preference mode surveillance . OUTLINE : This multicenter study . Quality-of-life questionnaire develop European Organization Research Treatment Cancer ( EORTC ) use . The EORTC QLQ-BLS24 24 question specific non-muscle-invasive bladder cancer EORTC QLQ-BLM30 30 question specific muscle-invasive bladder cancer combine use conjunction general cancer questionnaire QLQ-C30 . Assessments use QLQ-C30 make baseline entire cohort patient . Follow-up assessment use QLQ-C30 , QLQ-BLS24 , QLQ-BLM30 167 make first routine follow-up annually end study . Peer Reviewed Funded Endorsed Cancer Research UK .</detailed_description>
	<mesh_term>Urinary Bladder Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Inclusion criterion : Enrolled parent protocol CRUKBCPP200501 Bladder lesion cystoscopic characteristic compatible urothelial cancer transitional cell carcinoma meet 1 follow criterion : Nonmuscleinvasive tumor Muscleinvasive tumor Solitary G1 pTa tumor Exclusion criterion : Previous diagnosis cancer urethra , bladder , ureter , renal pelvis within 10 year prior current diagnosis PATIENT CHARACTERISTICS : Inclusion criterion : Fit cystoscopy surgical biopsy/resection Exclusion criterion : HIV infection Any condition , opinion local investigator , might interfere safety patient evaluation study objective PRIOR CONCURRENT THERAPY : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>transitional cell carcinoma bladder</keyword>
	<keyword>stage 0 bladder cancer</keyword>
	<keyword>stage I bladder cancer</keyword>
	<keyword>stage II bladder cancer</keyword>
</DOC>